1-11 of 11
F. Porzsolt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Biologic Relevance of Auto-Anti bodies against p53 in Patients with Metastatic Breast Cancer

Available to Purchase
Subject Area:
Oncology
F. Porzsolt, M. Schmid, D. Höher, R. Muche, W. Gaus, M. Montenarh
Journal: Onkologie
Onkologie (1994) 17 (4): 402–408.
https://doi.org/10.1159/000218446
Published Online: 11 May 2009
View articletitled, Biologic Relevance of Auto-Anti bodies against p53 in Patients with Metastatic Breast Cancer
Open the PDF for Biologic Relevance of Auto-Anti bodies against p53 in Patients with Metastatic Breast Cancer in another window
Journal Articles

Quality Assurance in Oncology: Definition of Treatment Goal and Assessment of Its Achievement

Available to Purchase
Subject Area:
Oncology
F. Porzsolt, A. Wirth, R. Mayer-Steinacker, P. Suhr, N. Warszawski, M. Schulte, G. Negri, L. Kleeberger, K.-H. Link, E. Betz, M.R. Sarkar, E. Röttinger
Journal: Onkologie
Onkologie (1994) 17 (4): 454–457.
https://doi.org/10.1159/000218454
Published Online: 11 May 2009
View articletitled, Quality Assurance in Oncology: Definition of Treatment Goal and Assessment of Its Achievement
Open the PDF for Quality Assurance in Oncology: Definition of Treatment Goal and Assessment of Its Achievement in another window
Journal Articles

Effectiveness and Utility of a Second-Line Treatment in Metastatic Breast Cancer

Available to Purchase
Subject Area:
Oncology
F. Porzsolt, R. Mayer-Steinacker, C. Eggl
Journal: Onkologie
Onkologie (1995) 18 (1): 48–52.
https://doi.org/10.1159/000218554
Published Online: 11 May 2009
View articletitled, Effectiveness and Utility of a Second-Line Treatment in Metastatic Breast Cancer
Open the PDF for Effectiveness and Utility of a Second-Line Treatment in Metastatic Breast Cancer in another window
Journal Articles

Subcutaneous IL-2 and Low-Dose IFN-α2a in the Treatment of Unselected Patients with Advanced Renal Cell Cancer

Available to Purchase
Subject Area:
Oncology
I. Funke, E. Späth-Schwalbe, G. Stohlmann, O. Prümmer, H. Gallati, H. Schrezenmeier, F. Porzsolt
Journal: Onkologie
Onkologie (1994) 17 (3): 263–269.
https://doi.org/10.1159/000218423
Published Online: 11 May 2009
View articletitled, Subcutaneous IL-2 and Low-Dose IFN-α2a in the Treatment of Unselected Patients with Advanced Renal Cell Cancer
Open the PDF for Subcutaneous IL-2 and Low-Dose IFN-α2a in the Treatment of Unselected Patients with Advanced Renal Cell Cancer in another window
Journal Articles

The Kinetics of Response are different in High-Risk and Low-Risk Patients with Metastatic Breast Cancer

Available to Purchase
Subject Area:
Oncology
F. Porzsolt, G. Meuret
Journal: Onkologie
Onkologie (1991) 14 (5): 428–432.
https://doi.org/10.1159/000217019
Published Online: 28 April 2009
View articletitled, The Kinetics of Response are different in High-Risk and Low-Risk Patients with Metastatic Breast Cancer
Open the PDF for The Kinetics of Response are different in High-Risk and Low-Risk Patients with Metastatic Breast Cancer in another window
Journal Articles

Response Rates and Toxicity of Mitomycin-C, Mitoxantrone, and Methotrexate (3M) in Advanced Breast Cancer

Available to Purchase
Subject Area:
Oncology
F. Porzsolt, G. Meuret
Journal: Onkologie
Onkologie (1991) 14 (4): 338–340.
https://doi.org/10.1159/000217002
Published Online: 28 April 2009
View articletitled, Response Rates and Toxicity of Mitomycin-C, Mitoxantrone, and Methotrexate (3M) in Advanced Breast Cancer
Open the PDF for Response Rates and Toxicity of Mitomycin-C, Mitoxantrone, and Methotrexate (3M) in Advanced Breast Cancer in another window
Journal Articles

Functional Criteria for Staging and Treatment of Hairy Cell Leukemia

Available to Purchase
Subject Area:
Oncology
F. Porzsolt, J. Demeter, H. Heimpel
Journal: Onkologie
Onkologie (1991) 14 (1): 44–48.
https://doi.org/10.1159/000216944
Published Online: 28 April 2009
View articletitled, Functional Criteria for Staging and Treatment of Hairy Cell Leukemia
Open the PDF for Functional Criteria for Staging and Treatment of Hairy Cell Leukemia in another window
Journal Articles

Konzept zur Behandlung metastasierender Mammakarzinome außerhalb von Universitätskliniken: Beschreibung der Methode und Prüfung der Effizienz

Available to Purchase
Subject Area:
Oncology
F. Porzsolt, W. Schreml, L. Buchelt, G. Meuret, S. Mende, P. Strigl, M. Redenbacher, D. Klumpp, M. Schmelz, R. Knöchelmann, V. Hiemeyer, K. Fleischer, E.-D. Kreuser, R. Leichtle, C. Popp, R. Kloiber
Journal: Onkologie
Onkologie (1987) 10 (6): 367–373.
https://doi.org/10.1159/000216445
Published Online: 27 April 2009
View articletitled, Konzept zur Behandlung metastasierender Mammakarzinome außerhalb von Universitätskliniken: Beschreibung der Methode und Prüfung der Effizienz
Open the PDF for Konzept zur Behandlung metastasierender Mammakarzinome außerhalb von Universitätskliniken: Beschreibung der Methode und Prüfung der Effizienz in another window
Journal Articles

Vorteile und Probleme multizentrischer Therapiestudien am Beispiel einer Studie zur Behandlung des metastasierenden Nierenzellkarzinoms mit rekombinantem Interferon-Alpha-2C

Available to Purchase
Subject Area:
Oncology
D. Messerer, F. Porzsolt, J. Hasford, A. Neiß
Journal: Onkologie
Onkologie (1987) 10 (1): 43–49.
https://doi.org/10.1159/000216367
Published Online: 24 April 2009
View articletitled, Vorteile und Probleme multizentrischer Therapiestudien am Beispiel einer Studie zur Behandlung des metastasierenden Nierenzellkarzinoms mit rekombinantem Interferon-Alpha-2C
Open the PDF for Vorteile und Probleme multizentrischer Therapiestudien am Beispiel einer Studie zur Behandlung des metastasierenden Nierenzellkarzinoms mit rekombinantem Interferon-Alpha-2C in another window
Journal Articles

Klinische Ökonomik: Anforderungen an Leitlinien und deren Erfüllbarkeit

Available to Purchase
Subject Area:
Oncology
F. Porzsolt, H. Leonhard-Huober
Journal: Onkologie
Onkologie (2000) 23 (4): 376–379.
https://doi.org/10.1159/000027172
Published Online: 07 September 2000
View articletitled, Klinische Ökonomik: Anforderungen an Leitlinien und deren Erfüllbarkeit
Open the PDF for Klinische Ökonomik: Anforderungen an Leitlinien und deren Erfüllbarkeit in another window
Journal Articles

Medizinischer Fortschritt und wirtschaftliche Patientenversorgung

Available to Purchase
Subject Area:
Oncology
F. Porzsolt
Journal: Onkologie
Onkologie (1998) 21 (6): 533–538.
https://doi.org/10.1159/000026901
Published Online: 18 January 1999
View articletitled, Medizinischer Fortschritt und wirtschaftliche Patientenversorgung
Open the PDF for Medizinischer Fortschritt und wirtschaftliche Patientenversorgung in another window